Metastatic BC cells also express RUNX2, a bone transcription factor that upregulates IHH and, in concert with SMAD activation by TGF-β, promotes osteolytic metastasis of the TNBC cell line MDA-MB-231 [135]. Here, IHH is linked to breast cancer.